vs

Side-by-side financial comparison of Dominion Energy (D) and Stryker Corporation (SYK). Click either name above to swap in a different company.

Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $4.2B, roughly 1.7× Dominion Energy). Dominion Energy runs the higher net margin — 13.9% vs 11.8%, a 2.1% gap on every dollar of revenue. On growth, Dominion Energy posted the faster year-over-year revenue change (23.2% vs 11.4%). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 9.3%).

Dominion Energy, Inc., commonly referred to as Dominion, is an American energy company headquartered in Richmond, Virginia that supplies electricity in parts of Virginia, North Carolina, and South Carolina and supplies natural gas to parts of Utah, Idaho and Wyoming, West Virginia, Ohio, Pennsylvania, North Carolina, South Carolina, and Georgia. Dominion also has generation facilities in Indiana, Illinois, Connecticut, and Rhode Island.

The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).

D vs SYK — Head-to-Head

Bigger by revenue
SYK
SYK
1.7× larger
SYK
$7.2B
$4.2B
D
Growing faster (revenue YoY)
D
D
+11.8% gap
D
23.2%
11.4%
SYK
Higher net margin
D
D
2.1% more per $
D
13.9%
11.8%
SYK
Faster 2-yr revenue CAGR
SYK
SYK
Annualised
SYK
16.9%
9.3%
D

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
D
D
SYK
SYK
Revenue
$4.2B
$7.2B
Net Profit
$586.0M
$849.0M
Gross Margin
64.5%
Operating Margin
18.0%
25.2%
Net Margin
13.9%
11.8%
Revenue YoY
23.2%
11.4%
Net Profit YoY
871.1%
55.5%
EPS (diluted)
$0.66
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
D
D
SYK
SYK
Q4 25
$4.2B
$7.2B
Q3 25
$4.5B
$6.1B
Q2 25
$3.7B
$6.0B
Q1 25
$4.1B
$5.9B
Q4 24
$3.4B
$6.4B
Q3 24
$3.8B
$5.5B
Q2 24
$3.5B
$5.4B
Q1 24
$3.5B
$5.2B
Net Profit
D
D
SYK
SYK
Q4 25
$586.0M
$849.0M
Q3 25
$1.0B
$859.0M
Q2 25
$760.0M
$884.0M
Q1 25
$646.0M
$654.0M
Q4 24
$-76.0M
$546.0M
Q3 24
$954.0M
$834.0M
Q2 24
$572.0M
$825.0M
Q1 24
$674.0M
$788.0M
Gross Margin
D
D
SYK
SYK
Q4 25
64.5%
Q3 25
63.6%
Q2 25
63.8%
Q1 25
63.8%
Q4 24
64.9%
Q3 24
64.0%
Q2 24
63.0%
Q1 24
63.6%
Operating Margin
D
D
SYK
SYK
Q4 25
18.0%
25.2%
Q3 25
29.7%
18.7%
Q2 25
29.5%
18.5%
Q1 25
29.9%
14.3%
Q4 24
11.4%
9.0%
Q3 24
32.2%
19.7%
Q2 24
23.3%
19.4%
Q1 24
23.6%
18.5%
Net Margin
D
D
SYK
SYK
Q4 25
13.9%
11.8%
Q3 25
22.3%
14.2%
Q2 25
20.4%
14.7%
Q1 25
15.8%
11.1%
Q4 24
-2.2%
8.5%
Q3 24
25.2%
15.2%
Q2 24
16.6%
15.2%
Q1 24
19.1%
15.0%
EPS (diluted)
D
D
SYK
SYK
Q4 25
$0.66
$2.20
Q3 25
$1.16
$2.22
Q2 25
$0.88
$2.29
Q1 25
$0.75
$1.69
Q4 24
$-0.11
$1.41
Q3 24
$1.12
$2.16
Q2 24
$0.65
$2.14
Q1 24
$0.78
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
D
D
SYK
SYK
Cash + ST InvestmentsLiquidity on hand
$250.0M
$4.0B
Total DebtLower is stronger
$44.1B
Stockholders' EquityBook value
$29.1B
$22.4B
Total Assets
$115.9B
$47.8B
Debt / EquityLower = less leverage
1.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
D
D
SYK
SYK
Q4 25
$250.0M
$4.0B
Q3 25
$932.0M
$3.3B
Q2 25
$344.0M
$2.4B
Q1 25
$355.0M
$2.3B
Q4 24
$310.0M
$3.7B
Q3 24
$1.8B
$3.9B
Q2 24
$139.0M
$1.9B
Q1 24
$265.0M
$2.3B
Total Debt
D
D
SYK
SYK
Q4 25
$44.1B
Q3 25
$43.3B
Q2 25
$40.3B
Q1 25
$39.9B
Q4 24
$37.5B
Q3 24
$37.1B
Q2 24
$36.6B
Q1 24
$35.1B
Stockholders' Equity
D
D
SYK
SYK
Q4 25
$29.1B
$22.4B
Q3 25
$27.7B
$21.8B
Q2 25
$27.2B
$21.2B
Q1 25
$27.4B
$20.9B
Q4 24
$27.3B
$20.6B
Q3 24
$27.5B
$20.1B
Q2 24
$27.1B
$19.8B
Q1 24
$27.4B
$19.2B
Total Assets
D
D
SYK
SYK
Q4 25
$115.9B
$47.8B
Q3 25
$111.6B
$47.1B
Q2 25
$107.4B
$46.3B
Q1 25
$104.6B
$46.0B
Q4 24
$102.4B
$43.0B
Q3 24
$99.8B
$43.8B
Q2 24
$100.4B
$39.1B
Q1 24
$102.0B
$39.4B
Debt / Equity
D
D
SYK
SYK
Q4 25
1.52×
Q3 25
1.56×
Q2 25
1.48×
Q1 25
1.46×
Q4 24
1.38×
Q3 24
1.35×
Q2 24
1.35×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
D
D
SYK
SYK
Operating Cash FlowLast quarter
$987.0M
$2.1B
Free Cash FlowOCF − Capex
$1.9B
FCF MarginFCF / Revenue
26.1%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
1.68×
2.52×
TTM Free Cash FlowTrailing 4 quarters
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
D
D
SYK
SYK
Q4 25
$987.0M
$2.1B
Q3 25
$1.9B
$1.5B
Q2 25
$1.2B
$1.1B
Q1 25
$1.2B
$250.0M
Q4 24
$641.0M
$1.9B
Q3 24
$1.5B
$1.5B
Q2 24
$856.0M
$633.0M
Q1 24
$2.0B
$204.0M
Free Cash Flow
D
D
SYK
SYK
Q4 25
$1.9B
Q3 25
$1.4B
Q2 25
$928.0M
Q1 25
$127.0M
Q4 24
$1.7B
Q3 24
$1.3B
Q2 24
$481.0M
Q1 24
$37.0M
FCF Margin
D
D
SYK
SYK
Q4 25
26.1%
Q3 25
22.3%
Q2 25
15.4%
Q1 25
2.2%
Q4 24
25.9%
Q3 24
23.7%
Q2 24
8.9%
Q1 24
0.7%
Capex Intensity
D
D
SYK
SYK
Q4 25
3.7%
Q3 25
3.1%
Q2 25
3.0%
Q1 25
2.1%
Q4 24
4.1%
Q3 24
3.1%
Q2 24
2.8%
Q1 24
3.2%
Cash Conversion
D
D
SYK
SYK
Q4 25
1.68×
2.52×
Q3 25
1.93×
1.79×
Q2 25
1.64×
1.26×
Q1 25
1.83×
0.38×
Q4 24
3.54×
Q3 24
1.61×
1.77×
Q2 24
1.50×
0.77×
Q1 24
2.94×
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

D
D

Dominion Energy Virginia$3.0B72%
Nonregulated Electricity Sales$334.0M8%
Contracted Energy$306.0M7%
Other$292.0M7%
Other Nonregulated Revenues$97.0M2%
Other Regulated Revenues$66.0M2%
Alternative Revenue Programs$50.0M1%
Transition Services Agreements$25.0M1%
Regulated Gas Transportation And Storage$10.0M0%
Related Party$5.0M0%

SYK
SYK

Medical$1.3B18%
Endoscopy$1.1B16%
Traumaand Extremities$1.1B15%
Instruments$925.0M13%
Knees$749.0M10%
Neuro Cranial$669.0M9%
Neurovascular$539.0M8%
Hips$499.0M7%
Other Orthopaedics$267.0M4%
Spine$8.0M0%

Related Comparisons